Table 4.
Multilevel Structural Equation Model for GSA Engagement and Anxiety Symptoms
Estimated Paths | Coefficient | SE | 95% CI |
---|---|---|---|
GSA Engagement to Wave 2 Mediators | |||
GSA engagement to perceived peer validation | 0.208*** | 0.043 | (0.123, 0.292) |
GSA engagement to self-efficacy to promote social justice | 0.330*** | 0.059 | (0.215, 0.446) |
GSA engagement to hope | 0.235*** | 0.076 | (0.086, 0.385) |
Wave 2 Mediators to Wave 2 Anxiety Symptoms | |||
Perceived peer validation to anxiety symptoms | −0.372 | 0.587 | (−1.522, 0.778) |
Self-efficacy to promote social justice to anxiety symptoms | 0.642 | 0.523 | (−0.383, 1.666) |
Hope to anxiety symptoms | −3.073*** | 0.504 | (−4.060, −2.086) |
Covariance among Wave 2 Mediators | |||
Peer validation and self-efficacy to promote social justice | 0.359*** | 0.066 | (0.230, 0.488) |
Peer validation and hope | 0.424*** | 0.074 | (0.280, 0.569) |
Self-efficacy to promote social justice and hope | 0.778*** | 0.103 | (0.577, 0.979) |
Autoregressive Associations at Level 1 | |||
W1 perceived peer validation to W2 perceived peer validation | 0.346*** | 0.055 | (0.238, 0.454) |
W1 self-efficacy to promote social justice to W2 self-efficacy to promote social justice | 0.437*** | 0.045 | (0.349, 0.524) |
W1 hope to W2 hope | 0.457*** | 0.036 | (0.386, 0.527) |
W1 anxiety symptoms to W2 anxiety symptoms | 0.615*** | 0.032 | (0.553, 0.678) |
Demographic Covariates to Wave 2 Anxiety Symptoms | |||
Sexual minority identity to anxiety symptoms (heterosexual as referent) | −0.367 | 1.426 | (−3.161, 2.427) |
Racial/ethnic minority identity to anxiety symptoms (White as referent) | −0.518 | 1.284 | (−3.035, 1.998) |
Cisgender male to anxiety symptoms (cisgender female as referent) | −3.239* | 1.585 | (−6.346, −0.132) |
Gender expansive to anxiety symptoms (cisgender female as referent) | −0.917 | 1.355 | (−3.572, 1.739) |
Group-level Predictors to Wave 2 Group-Level Anxiety Symptoms | |||
W1 anxiety symptoms to W2 anxiety symptoms | 0.675* | 0.288 | (0.110, 1.241) |
Mental health-related discussions to anxiety symptoms | −0.216 | 0.685 | (−1.558, 1.126) |
Advisor self-efficacy to address SGM issues to anxiety symptoms | 1.115 | 1.226 | (−1.288, 3.518) |
Number of GSA meetings to anxiety symptoms | −0.252** | 0.093 | (−0.435, −0.069) |
Note. Values are unstandardized coefficient estimates, their standard errors (SE), and 95% confidence intervals (CI). W1 = Wave 1; W2 = Wave 2.
p < .001.
p < .01.
p < .05.